Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Beckman Coulter, Inc.250 enrolled

Overview

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Obstructive Sleep Apnea

Interventions

blood biomarkerDIAGNOSTIC_TEST

Eligibility

Sex: MALEMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Written Informed Consent * Male * 18-70 years old * Presentation with symptoms suggestive of obstructive sleep apnea * Diagnostic sleep study * Blood draw Exclusion Criteria: * Prior (within past year) or current therapy for sleep apnea * Use of opioid pain medication, steroids or allopurinol (within past 30 days) * Use of chronic anti-inflammatory drugs (within past 7 days) * Active cancer under current treatment or monitoring

Locations (3)

Sleep Center Orange County

Irvine, California, United States

Brigham and Women's Hospital

Boston, Massachusetts, United States

SleepMed

Columbia, South Carolina, United States

Outcomes

Primary Outcomes

Identification of OSA in high-risk individuals

Time frame: 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.